Clinical Trial

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

Study acronym: PE-TRACT
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
PE-TRACT is an open-label, assessor-blinded, randomized trial, aiming to compare catheter-directed therapy (CDT) and anticoagulation (CDT group) with anticoagulation alone (No-CDT) in 500 patients with submassive PE, proximal pulmonary artery thrombus and right ventricular dilation.
Protocol Amendment History 1 change
minor Completion pushed: 2027-06-26 -> 2027-08-04 2026-05-19
Trial Details
NCT Number NCT05591118
Lead Sponsor NYU Langone Health
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Pulmonary Embolism
Enrollment 500 participants
Start Date 2023-07-17
Primary Completion 2027-03-29 (estimated)
Study Completion 2027-08-04 (estimated)
Updated on ClinicalTrials.gov 2026-05-18